Tomorrow's Headlines: 3 Positive Signs
Karen Finerman explains that she sees opportunities for corporate buyers (as opposed to private equity buyers) as well as foreign buyers because the dollar is weak. She likes Meriden Gold (MDG) as a trade because the company is the object of a hostile takeover bid as well as other bids.
Pete Najarian tells the panel to keep an eye on the medical devices space for M&A activity. He believes Biomet (BMET) is a deal that will go through. He’s also watching Dade Behring (DADE) as well as Ventana (VMSI) and Roche (ROG).
Jeff Macke scoffs and says if this is the best the market can do, he’s not impressed.
Got something to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to firstname.lastname@example.org.
Trader disclosure: On Sept. 6, 2007, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (JWN); Najarian Owns (CHL), (BJS);Finerman's Firm Owns (WMT); Finerman's Firm Owns S&P 500 Puts; Finerman's Firm Owns Russell 2000 Puts; Finerman's Firm Is Long (MDG) And Is Short (AUY) Against It.